Upload
heri-fitrianto
View
222
Download
0
Embed Size (px)
Citation preview
8/10/2019 UTI Pathogenesis and Diagnosis,
1/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 1
Urinary tract infectionCommensal Non-pathogenic colonising organism in healthy hostPathogen Organism with an ability to cause diseaseVirulence Degree of pathogenicityBacteriuria Presence of bacteria in urine
UTI Bacterial invasion of the urothelium resulting ininflammatory response
Opportunistic inf. UTI caused by non-pathogens due to weakened hostdefences
Isolated inf. First infection or separated from last infection by 6months
Unresolved inf. Denoted by failed resolution of UTI on culturedespite ABx. Due to:
Initial bacterial resistanceAcquired bacterial resistanceMultiple organismsselective overgrowth of
resistant strainRenal impairmentreduced urinary concentrationStaghorn calculusPoor compliance
Recurrent inf. UTI after confirmed resolution on cultureDefined as 2 infections in 6 months or 3 in a yearDivided into re-infection and persistenceReinfection - from outside UT (usually ascending)accounts for 95% all recurrent UTIs in femalestypicallydifferent organisms, but not always.Persistence - from within UT more common in males andhighlighted by rapid infection with same organism
Complicated inf. UTI a/w higher likelihood of sepsis, tissue necrosis, organdysfunction and death. Factors a/w complicated UTI:
Functional/structural UT abnormality*Male sexElderlyPregnantHistory of childhood UTIFebrile UTILikely obstruction
History of stone diseaseDM, immunosuppression, renal impairmentRenal tract instrumentationRecent antibiotic therapyDuration of therapy longer than 7 days
* Catheter in situPVR > 100mlNeurogenic bladderObstuctive uropathyVUR
Urinary diversion
8/10/2019 UTI Pathogenesis and Diagnosis,
2/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 2
PathogenesisClinical significance of UTI dependent on type of organism, bacterial virulenceand host defence factors
A. Types of organism
Community E. Coli (85%)Other enterobacteria (5-10%)
KlebsiellaProteus*Enterococcus faecalisPseudomonasProvidentia*CitrobacterSerratia
Staph. Saprophyticus (10-30% of young women)* more common in men
Hospital E. Coli (50%)PseudomonasEnterococcusCitrobacter
B. Bacterial virulence factorsFimbrial adhesins
Type 1 piliCommonest typeMannose-sensitive haemagglutinin (addition of mannosecan prevent/reverse haemagglutination)Bind to uroplakins 1a and 1b
Type p piliLess commonType II found in ~80% pyelonephritisType III found in cystitis(Type 1 in animals only)mannose-insensitive haemagglutininbinds to p blood group antigens
Non-fimbrial adhesins
Glycocalyx(e.g. Dr adhesins on E Coli)Toxin productionEndotoxin produced from GNB [lipopolysaccharide secretedfrom outer membrane of bacterial cell wall: lipid componenttoxic; polysaccharide component immunogenic. Heat stable toboiling point]
HaemolysinsEnzyme secretion (protease, urease etc.)Swarming factor (P.mirabilis)Avoidance of phagocytosis
Intracellular growth
Biofilm formation
8/10/2019 UTI Pathogenesis and Diagnosis,
3/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 3
C. Host defenceUrinary flowUrinary acidityUrinary osmolality (high or very low)Tamm-Horsfall protein (uromodulin)
From AloH and DCTBinds type 1/type S fimbriated bacteriaActivates phagocytosis
Mucosal defenseIgALysozymeLactoferrinBladder mucin
Commensal bacteriaLactobacillus acidophilusOestrogensglycogenmetabolised by l.a. to lactic acidpH
drop inhibitory to pathogensGeneral integrity of immune system
InnateAcquired (Humoral and cell-mediated)
Genetic susceptibilityHLA-A3 antigen a/w 4x risk of recurrent UTI (?why)Non-secretor phenotype for Lewis blood group antigens
Diagnosis
Urine dipstick testingUrinary nitrite and leukocyte esterase surrogates for bacteria and WBCrespectively. Reference bacteruria > 10
5orgs/ml
Early morning urine has increased sensitivityUrinary Nitrite
Dietary nitrates - urinary nitrates - nitrate reducing bacteria(enterobacteria) -urinary nitrites - react with amine-impregnated dipstixreagent - pink diazonium compoundSensitivity = 35-85%, Specificity = 92-100%False positives:
Contamination
False negatives:Nonenteric bacteriaDilute urine/ frequent voidingVitamin CHigh osmolality/ urinary H+Urobilinogen
Urinary Leukocyte EsteraseLE from neutrophil/ basophil granules reacts with reagent strip -indoxyl moeity produces colour changes by oxidation of diazonium saltSensitivity = 72-97%, Specificity = 64-82%False positives
Specimen contaminationFalse negatives
8/10/2019 UTI Pathogenesis and Diagnosis,
4/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 4
Old specimen (leucocyte lysis)High osmolality/specific gravityVitamin CUrobilinogen
When Nitrite and LE combined; Sensitivity = 70-100%, Specificity = 60-98%
Urine microscopy and cultureClean catch MSU specimenFirst voided morning specimenexamine within one hourCentrifuged samples 5 mins at 3000rpmresuspendExamine at low power (100x) and high power (400x) 1 hpf = 1/20,000 mlRoutine examination for:
RBCsRBC casts GlomerulonephritisWBCs > 10wbc/hpf = significant inflammationWBC casts Pyelonephritis
Bacteria 5/hpf = 100,000/ml*
* Significance controversial. Original studies by Kass (1950s). Found that only15% women with 50% with counts over 100,000/ml had Hx UTI and organisms typicallypathogenic. However well known that a subpopulation of women (up to 30%)can have symptomatic UTI with counts 10
3-10
5orgs/ml (Finding of pyuria can
be very helpful)
EAU significance criteria 10
3cfu/ml in women with acute uncomplicated cystitis
104cfu/ml in women with acute uncomplicated pyelonephritis 10
5cfu/ml in women with complicated UTI
105cfu/ml in asymptomatic bacteriuria in pregnancy
104cfu/ml in men with complicated UTI
Asymptomatic bacteruriaSeldom associated with adverse outcomes except in following groups:
ChildrenPregnant females
Before urological proceduresScreening or treatment not of proven benefit in following groups:Pre-menopausal womenDiabetic womenElderly patientsSpinal cord injuryCatheterised patients
8/10/2019 UTI Pathogenesis and Diagnosis,
5/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 5
Urosepsis
SIRSremember acronym THReW
Severe sepsis and organ dysfunction:
Severe sepsis and septic shock a/w mortality 20-40% (recently ~18%)Urogenital tract a source in ~5%Increased incidence and mortality in elderly, diabetics and immuno-compromised. TNF-a, IL-1, IL-6 and IL-8 commonly implicated cytokinesC-reactive peptide and particularly procalcitonin believed to be specific forbacterial vs. viral/other infections
ManagementSimultaneous investigation, resuscitation and treatment
See Surviving SepsisCampaignrecommendations belowEstablish IV access2 large bore cannulae antecubital fossae
8/10/2019 UTI Pathogenesis and Diagnosis,
6/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 6
Send blood for FBC, U+E, LFTs, CRP, serum lactate and clottingArterial blood gasesBlood cultures
2 peripheral cultures + and line > 48 hours oldUrine culture and catheterisation
Fluid resuscitation20ml/kg crystalloid or equivalent1000ml or 330ml colloid over 30minsSlow fluids and refer for inotropes/CVP monitoring if refractoryhypotension after 20ml/kg fluid challenge (~1500ml in 75kgman)
High-flow oxygen therapyBroad spectrum antibioticsConsider further adjunctive measures
Relief of urinary obstructionDebridement of necrotic tissue
Early ITU opinionCentral venous and arterial pressure and cardiac indexmeasurementInotrope administration (if MAP
8/10/2019 UTI Pathogenesis and Diagnosis,
7/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 7
8/10/2019 UTI Pathogenesis and Diagnosis,
8/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 8
8/10/2019 UTI Pathogenesis and Diagnosis,
9/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 9
AppendixHuman infective organisms (in descending size order):
ArthropodsHelminths
Nematodes, cestodes & trematodes (including schistosomiasis)
EukaryotesProtazoaFungi
ProkaryotesBacteriaRickettsiaeChlamydiaMycoplasmaSpirochaetes
VirusesRNA (HIV, HAV, HCV)
DNA (Herpes, HPV, HBV)
8/10/2019 UTI Pathogenesis and Diagnosis,
10/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 10
Parasites Arthropods, helminths and protozoaEukaryotes > 1 chromosome, double membrane intracellular structuresProkaryotes 1 chromosome, no nuclear membrane, no mitochondria
Gram +ve Gram ve
Cocci
StaphylococciCoagulase +ve S. aureusCoagulaseve S. epidermidis
Streptococci-haemolytic
Gp A S. pyogenesGp B,C,D Neonatal
infections-haemolytic S. viridans,
S. pneumoniae
non-haemolytic S. bovisE. faecalis
Neisseria meningitidisNeisseria gonorrhoea
Rods
BacilliAerobic
Bacillus anthracisCoynebacterium diphtheriaeListeria monocytogenesNocardia
AnaerobicClostridia botulinum
perfringenstetanidifficile
Actinomyces israelii
EnterobacteriaceaeE. ColiProteus mirabilisKlebsiellaSalmonellaShigellaeneterobacterSerratiaYersinia
Haemophilus InfluenzaeBrucellaPseudomonasLegionellaHelicobacter PyloriBacteroides (anaerobic)
Beta haemolysis = clear zone of haemolysis on blood agar due tohaemolysins O and SAlpha haemolysis = partial clearing with green discoloration not due tohaemolysins
Gram stainingGram-positive bacteria have a thick mesh-like cell wall made ofpeptidoglycan(50-90% of cell wall), which stains purple while gram-negative bacteria have athinner layer (10% of cell wall), which stains pink.4 steps:
Crystal violet both types stain purple
Iodine CV trapped in cells
http://en.wikipedia.org/wiki/Peptidoglycanhttp://en.wikipedia.org/wiki/Peptidoglycan8/10/2019 UTI Pathogenesis and Diagnosis,
11/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 11
Ethanol wash Degrades GN cell membrane and leaches CV fromGNB. No effect on GPB
Safranin Counterstain allows identification of translucentGNB
Multi-resistant organismsESBL
Extended spectrum beta lactamaseTend to be carried in bowelimpossible to eradicate with antibioticsand promotes overgrowth and further resistanceResistant to third-generation cephalosporins and monobactamsRetained sensitivity to cefomycins (e.g. cefotetan) carbapenems (e.g.imipenem)Also sensitive to beta-lactamase inhibitors like clavulanic acid but co-
amoxyclav does not work clinicallytoo much beta lactamaseproduced to allow amoxycillin to be efficacious
Plasmid mediatedexplains cross-resistance among organisms andtherefore reason for isolation
MRSAMethicillin-resistant staphylococcus aureusResistant to all penicillins, including those with beta lactamase (due tothe production of penicillin-binding protein PBP-2Vancomycin and teicoplanin always sensitive; fusidic acid, rifampicinusually, trimethoprim and doxycycline occasionally; cipro neverMRSA prostatitis may be troublesome
IV vancomycin/teicoplaninPO doxycycline, trimethoprim, rifampicin or if desperate linezolid
Oral vancomycin does not get absorbedonly for CDTVRE
Low grade infectionsgenerally not septicSpectrum narrowIV or PO linezolid
Surviving sepsis resuscitation and management bundles
8/10/2019 UTI Pathogenesis and Diagnosis,
12/12
UTIPathogenesis and diagnosis
Tom Walton January 2011 12